These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 3389211

  • 1. [Comparative study of 62 patients randomly treated with adriamycin or cisplatin as chemoprophylaxis of their superficial bladder carcinoma].
    Iborra Juan I, Monrós Lliso JL, Ricós Torrent JV, Mazcuñan Fuentes F, Casanova Ramón-Borja J, Solsona Narbón E.
    Actas Urol Esp; 1988; 12(1):20-4. PubMed ID: 3389211
    [No Abstract] [Full Text] [Related]

  • 2. [Comparative study of thiotepa, adriamycin and cisplatin in the prophylaxis of recurrence of superficial bladder carcinoma in a group of 217 patients].
    Llopis B, Gallego J, Boronat F, Moreno B, Mompó JA, Jiménez JF.
    Actas Urol Esp; 1986; 10(4):225-30. PubMed ID: 3092589
    [No Abstract] [Full Text] [Related]

  • 3. [Comparative study of 3 series of patients treated respectively with thiotepa, adriamycin and cisplatin].
    Nogueira March JL, Ojea A, Jamardo D, Figueiredo L.
    Actas Urol Esp; 1984; 8(4):325-8. PubMed ID: 6435407
    [No Abstract] [Full Text] [Related]

  • 4. [Prognostic factors and risk of recurrence in a series of 385 patients with superficial bladder carcinoma treated with thiotepa, adriamycin or cisplatin].
    Llopis B, Sánchez A, Boronat F, Gallego J, Moreno B, Alonso M, Martínez R, Vera CD, Jiménez JF.
    Arch Esp Urol; 1987 Apr; 40(3):159-64. PubMed ID: 3113347
    [No Abstract] [Full Text] [Related]

  • 5. The effect of cystectomy, and perioperative methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy on the risk and pattern of relapse in patients with muscle invasive bladder cancer.
    Ennis RD, Petrylak DP, Singh P, Bagiella E, O'Toole KM, Benson MC, Olsson CA.
    J Urol; 2000 May; 163(5):1413-8. PubMed ID: 10751847
    [Abstract] [Full Text] [Related]

  • 6. [Directed chemotherapy in superficial carcinoma of the bladder conditioned by the knowledge of recurrence factors].
    Oliver F, Llopis B, Vera C, Domínguez C, Vidal J, Gallego J, Jiménez JF.
    Actas Urol Esp; 1989 May; 13(1):41-3. PubMed ID: 2496584
    [Abstract] [Full Text] [Related]

  • 7. [Prevention of the recurrence of bladder tumors with local adriamycin therapy].
    Somogyi L, Török A, Bors G, Frang D.
    Orv Hetil; 1984 Oct 07; 125(41):2503-6. PubMed ID: 6493764
    [No Abstract] [Full Text] [Related]

  • 8. Crossed chemoprophylaxis assay between adriamycin and cis-platinum in recurrent superficial bladder tumor.
    Llopis B, Gallego J, Mompó JA, Boronat F, Alonso M, Moreno B, Jiménez JF.
    Eur Urol; 1986 Oct 07; 12(4):253-6. PubMed ID: 3091370
    [Abstract] [Full Text] [Related]

  • 9. [Prevention of recurrence in non-invasive bladder carcinoma. Experiences with 400 patients].
    Burk K, Troller RM, Pittner P.
    Urologe A; 1983 Sep 07; 22 Suppl():332-6. PubMed ID: 6356556
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Comparative study of adriamycin and thiotepa in the chemoprophylaxis of superficial bladder tumors].
    Salinas Sánchez AS, Moreno Avilés J, Pérez Albacete M, Salmerón Lopez-Rua J, Guardiola Más A, Server Falgas G.
    Actas Urol Esp; 1989 Sep 07; 13(2):99-102. PubMed ID: 2499166
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Characteristic and effective usage of adriamycin].
    Horiuchi K, Akimoto M.
    Gan To Kagaku Ryoho; 1996 Dec 07; 23(14):1916-9. PubMed ID: 8978797
    [Abstract] [Full Text] [Related]

  • 20. Can patient selection for bladder preservation be based on response to chemotherapy?
    Sternberg CN, Pansadoro V, Calabrò F, Schnetzer S, Giannarelli D, Emiliozzi P, De Paula F, Scarpone P, De Carli P, Pizzo M, Platania A, Amini M.
    Cancer; 2003 Apr 01; 97(7):1644-52. PubMed ID: 12655521
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.